KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Beginning Cash Balance (2017 - 2025)

Historic Beginning Cash Balance for Amneal Pharmaceuticals (AMRX) over the last 3 years, with Q3 2024 value amounting to $32.7 million.

  • Amneal Pharmaceuticals' Beginning Cash Balance changed N/A to $32.7 million in Q3 2024 from the same period last year, while for Sep 2025 it was $32.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $44.2 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Beginning Cash Balance of $32.7 million as of Q3 2024.
  • Amneal Pharmaceuticals' 5-year Beginning Cash Balance high stood at $32.7 million for Q3 2024, and its period low was $1.0 million during Q1 2021.